Wellington Management Group LLP Has $2.57 Billion Stake in Stryker Corporation $SYK

Wellington Management Group LLP raised its stake in shares of Stryker Corporation (NYSE:SYK) by 0.6% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 8,167,185 shares of the medical technology company’s stock after acquiring an additional 45,478 shares during the quarter. Wellington Management Group LLP’s holdings in Stryker were worth $2,571,357,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Brighton Jones LLC grew its holdings in shares of Stryker by 15.4% during the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock worth $1,643,000 after purchasing an additional 609 shares in the last quarter. Schnieders Capital Management LLC. bought a new stake in shares of Stryker during the second quarter valued at approximately $205,000. Marshall Wace LLP raised its stake in shares of Stryker by 107.9% in the second quarter. Marshall Wace LLP now owns 5,700 shares of the medical technology company’s stock valued at $2,255,000 after purchasing an additional 77,831 shares in the last quarter. Nebula Research & Development LLC acquired a new position in shares of Stryker in the second quarter valued at $219,000. Finally, HUB Investment Partners LLC bought a new position in Stryker in the second quarter worth $253,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Insider Activity at Stryker

In other Stryker news, Director Ronda E. Stryker sold 300,000 shares of the business’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $335.90, for a total value of $100,770,000.00. Following the transaction, the director directly owned 2,301,375 shares in the company, valued at $773,031,862.50. The trade was a 11.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Dylan Bram Crotty sold 441 shares of the company’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $328.61, for a total transaction of $144,917.01. Following the sale, the insider directly owned 6,102 shares in the company, valued at $2,005,178.22. This represents a 6.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 351,267 shares of company stock valued at $118,197,701 in the last ninety days. Insiders own 4.60% of the company’s stock.

Analysts Set New Price Targets

SYK has been the topic of several analyst reports. The Goldman Sachs Group reissued a “neutral” rating and issued a $361.00 price target on shares of Stryker in a report on Friday, May 1st. Wolfe Research downgraded shares of Stryker from an “outperform” rating to a “peer perform” rating in a report on Thursday, August 13th. Citizens Jmp decreased their target price on shares of Stryker from $440.00 to $400.00 and set a “market outperform” rating on the stock in a research report on Monday, August 3rd. Weiss Ratings reissued a “hold (c)” rating on shares of Stryker in a research note on Friday, July 31st. Finally, UBS Group started coverage on shares of Stryker in a research report on Tuesday, July 28th. They issued a “buy” rating and a $400.00 price target for the company. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $386.28.

Stryker Stock Performance

Shares of NYSE:SYK opened at $331.32 on Friday. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33. The business’s fifty day moving average price is $329.10 and its two-hundred day moving average price is $331.47. Stryker Corporation has a fifty-two week low of $281.00 and a fifty-two week high of $396.86. The stock has a market capitalization of $127.08 billion, a price-to-earnings ratio of 34.33, a price-to-earnings-growth ratio of 2.05 and a beta of 0.76.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The company had revenue of $6.59 billion during the quarter, compared to analysts’ expectations of $6.58 billion. During the same period last year, the business earned $3.13 earnings per share. The business’s revenue was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, analysts predict that Stryker Corporation will post 15.02 EPS for the current fiscal year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Wednesday, September 30th. Stryker’s dividend payout ratio (DPR) is currently 36.48%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.